04:58 PM EDT, 03/25/2025 (MT Newswires) -- 2seventy bio (TSVT) reported a Q4 loss Tuesday of $0.37 per diluted share, narrowing from the loss of $1.11 a year earlier.
Four analysts polled by FactSet expected a loss of $0.20.
Revenue in the three months ended Dec. 31 fell to $2.93 million from $10.7 million a year earlier.
Three analysts surveyed by FactSet projected $13.7 million.